The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

Drugs giant struggling to manage slump in demand for Covid vaccines and antivirals as it falls behind rivals on obesity ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

Leaders from across the health care field met recently in Chicago at the Oliver Wyman Health Innovation Summit to explore how ...

The recommendations, to administer both the shot and the antibody or either, come after the WHO's strategic advisory group on ...

With Tuesday’s announcement, Eastern North Carolina adds to its reputation for large-scale pharmaceutical manufacturing, as ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

An OPEC+ panel is unlikely this week to recommend any changes to its current deal to reduce production and to start unwinding ...

“Right now is the best time” to get all the recommended fall vaccinations, said Dr. Mandy Cohen, director of the Centers for ...

Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual ...